| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 618.38B | 617.66B | 623.56B | 553.12B | 487.30B | 440.06B |
| Gross Profit | 90.62B | 89.66B | 91.58B | 64.65B | 54.97B | 52.12B |
| EBITDA | 58.23B | 60.81B | 56.35B | 42.56B | 31.90B | 37.75B |
| Net Income | 25.41B | 27.81B | 24.85B | 10.90B | 3.57B | 12.03B |
Balance Sheet | ||||||
| Total Assets | 514.10B | 510.94B | 519.72B | 456.15B | 447.83B | 419.26B |
| Cash, Cash Equivalents and Short-Term Investments | 113.42B | 98.27B | 78.52B | 70.03B | 62.78B | 76.90B |
| Total Debt | 10.00B | 11.06B | 11.25B | 10.99B | 10.89B | 10.97B |
| Total Liabilities | 175.68B | 173.06B | 180.23B | 159.74B | 162.29B | 148.98B |
| Stockholders Equity | 316.37B | 316.08B | 317.87B | 277.38B | 268.71B | 255.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.57B | 26.40B | 4.22B | -3.40B | 18.52B |
| Operating Cash Flow | 0.00 | 39.31B | 53.27B | 26.75B | 14.68B | 34.68B |
| Investing Cash Flow | 0.00 | -26.17B | -31.45B | -8.23B | -26.00B | -26.89B |
| Financing Cash Flow | 0.00 | -7.98B | -22.57B | -6.54B | -6.44B | -5.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥261.91B | 8.29 | ― | 3.36% | 1.36% | 139.77% | |
79 Outperform | ¥440.70B | 11.25 | ― | 1.60% | -5.16% | 200.96% | |
75 Outperform | ¥499.84B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥150.10B | 10.91 | ― | 2.93% | 1.77% | 117.03% | |
70 Outperform | ¥55.30B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥212.77B | 16.01 | ― | 4.77% | -3.71% | -51.81% |